BRIEF published on 11/06/2024 at 07:35, 1 year 6 months ago Sensorion participera aux principales conférences d'investisseurs en novembre 2024 Biotechnologie Conférences D'investisseurs Sensorion Thérapies Pour La Perte Auditive Développement De La Thérapie Génique
PRESS RELEASE published on 11/06/2024 at 07:30, 1 year 6 months ago Inside Information / Other news releases Sensorion to participate in upcoming investor conferences in November 2024, including Stifel Healthcare Conference and LifeSci Capital & Sofinnova Partners Summit Biotechnology Investor Conferences Clinical-stage Sensorion Hearing Loss Disorders
PRESS RELEASE published on 11/06/2024 at 07:30, 1 year 6 months ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à plusieurs conférences investisseurs en novembre 2024. Découvrez les événements à venir et les programmes de thérapie de l'entreprise Biotechnologie Conférences Investisseurs Événements Sensorion Thérapies Auditives
BRIEF published on 09/20/2024 at 07:35, 1 year 7 months ago Sensorion dévoile de nouvelles avancées cliniques prometteuses Biotechnologie Essais Cliniques Thérapie Génique Perte Auditive Petite Molécule
BRIEF published on 09/20/2024 at 07:35, 1 year 7 months ago Sensorion Unveils Promising New Clinical Advances Biotechnology Clinical Trials Gene Therapy Hearing Loss Small Molecule
PRESS RELEASE published on 09/20/2024 at 07:30, 1 year 7 months ago Informations privilégiées / Autres communiqués Sensorion annonce de nouvelles données cliniques positives lors du Congrès Mondial d'Audiologie à Paris concernant les programmes de thérapie génique et de petite molécule Thérapie Génique Sensorion Données Cliniques Petite Molécule Congrès Mondial D'Audiologie
PRESS RELEASE published on 09/20/2024 at 07:30, 1 year 7 months ago Inside Information / Other news releases Sensorion announces positive clinical data on gene therapy and small molecule programs at World Congress of Audiology, Paris. Details by key medical professionals Clinical Data Gene Therapy Sensorion World Congress Of Audiology Small Molecule
BRIEF published on 09/18/2024 at 07:35, 1 year 7 months ago Sensorion Reports First Half 2024 Financial Results and Clinical Advances Clinical Trials Gene Therapy 2024 Financial Results Sensorion Hearing Loss Therapies
BRIEF published on 09/18/2024 at 07:35, 1 year 7 months ago Sensorion annonce ses résultats financiers et ses avancées cliniques pour le premier semestre 2024 Essais Cliniques Thérapie Génique Résultats Financiers 2024 Sensorion Thérapies Pour La Perte Auditive
PRESS RELEASE published on 09/18/2024 at 07:30, 1 year 7 months ago Half yearly financial reports and audit reports/limited reviews / Half yearly financial report Sensorion reports 2024 first half results including progress on SENS-501 and SENS-401 programs. Cash position strong at €87m. Future milestones and financial highlights outlined Sensorion Hearing Loss SENS-401 SENS-501 2024 Results
Published on 05/14/2026 at 08:00, 10 minutes ago Touchstone Exploration Reports First Quarter 2026 Results and Operational Update
Published on 05/14/2026 at 04:15, 3 hours 55 minutes ago Battery X Metals Announces Corporate Awareness Engagement
Published on 05/14/2026 at 03:15, 4 hours 55 minutes ago Jaguar Delivers Strong Adjusted Earnings and Strategic Production Restart of MTL (Turmalina Mine) in Q1 2026
Published on 05/14/2026 at 07:50, 20 minutes ago RBI publishes voluntary public tender offer for all Addiko shares at EUR 26.50 per share
Published on 05/14/2026 at 07:00, 1 hour 10 minutes ago Brockhaus Technologies AG: Revenue in Q1 2026 for the continuing and discontinued operations totaled €47.9 million, with adjusted EBITDA of €7.6 million
Published on 05/14/2026 at 03:20, 4 hours 50 minutes ago TCL Electronics (01070.HK) Maintains Strong Growth in Q1 2026
Published on 05/14/2026 at 01:05, 7 hours 5 minutes ago THE ROYAL MINT SHINES A LIGHT ON PINK FLOYD WITH FIRST EVER UK COMMEMORATIVE COIN
Published on 05/13/2026 at 18:02, 14 hours 8 minutes ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Published on 05/13/2026 at 18:00, 14 hours 10 minutes ago ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires
Published on 05/13/2026 at 17:45, 14 hours 25 minutes ago Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.
